<code id='68FD1975DF'></code><style id='68FD1975DF'></style>
    • <acronym id='68FD1975DF'></acronym>
      <center id='68FD1975DF'><center id='68FD1975DF'><tfoot id='68FD1975DF'></tfoot></center><abbr id='68FD1975DF'><dir id='68FD1975DF'><tfoot id='68FD1975DF'></tfoot><noframes id='68FD1975DF'>

    • <optgroup id='68FD1975DF'><strike id='68FD1975DF'><sup id='68FD1975DF'></sup></strike><code id='68FD1975DF'></code></optgroup>
        1. <b id='68FD1975DF'><label id='68FD1975DF'><select id='68FD1975DF'><dt id='68FD1975DF'><span id='68FD1975DF'></span></dt></select></label></b><u id='68FD1975DF'></u>
          <i id='68FD1975DF'><strike id='68FD1975DF'><tt id='68FD1975DF'><pre id='68FD1975DF'></pre></tt></strike></i>

          Home / knowledge / Wikipedia

          Wikipedia


          Wikipedia

          author:focus    Page View:6
          A scientist working at SQZ Biotechnologies in Watertown's Arsenal Yards. -- biotech coverage from STAT
          A scientist working at SQZ Biotechnologies in Watertown, Mass. David L Ryan/Globe Staff

          Next stop: Beacon Hill.

          Governor Maura Healey’s long-awaited plan to double down on state funding for the biotech and medical technology sector came into focus Thursday with the announcement she’ll seek $1 billion over the next decade to reauthorize the state’s 16-year-old life sciences initiative.

          advertisement

          But lawmakers so far are noncommittal on funding the plan. The proposal — dubbed “Life Sciences 3.0″ — is part of a larger economic development bill the Healey administration is expected to file soon. Several expressed support for an industry in which Massachusetts is a leader, but also noted the spending request comes at a time of competing priorities.

          Get unlimited access to award-winning journalism and exclusive events.

          Subscribe Log In